Tag Archives: BIO International Convention

Americans, Biotech Execs, Convention Attendees Optimistic About Biotech

Key Findings From A  National Survey Of Voters

What does the future hold for biotechnology? After surveying American voters, biotech executives, and attendees here the 2012 BIO International Convention, we learned that the future is indeed bright.  More than three quarters of American voters, nearly all the biotech execs, and 1,400 of the attendees we spoke to are optimistic that science and technology will find cures to help patients suffering from serious diseases, such as cancer, diabetes, Alzheimer’s, Parkinson’s and HIV/AIDS. Tempering that Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , , , ,

An Insider’s View of the BioGENEius Challenge

BioGENEius Challenge

By Erica Hiar, Environics A big highlight every year for many attendees at BIO International Convention is the announcement of the winner of the International BioGENEius Challenge, a competition for high school students who demonstrate an exemplary understanding of biotechnology through science research projects. But for me, the true excitement was the ride getting there. Four hundred thirty-five students applied for the U.S. International BioGENEius challenge and hundreds more applied to the Canadian and Western Read More >

Events  |  Leave a comment  |  Email This Post
Tags: , , , ,

Phase III Assets in High Demand – Results from the Business Forum Meeting Activity

Picture1-thumb

At the BIO International Convention in Boston today, we released our results from the Business Forum meeting activity. This analysis provides a real-time snapshot of what in-licensors from pharma and biotech are looking for here at the conference. The Business Forum hit over 25,000 scheduled One-on-One Partnering™ meetings on Monday afternoon.  This is 18% more meetings than last year, and more than double the meetings held back in 2007, when we last held this event in Read More >

Inside BIO Industry Analysis  |  Leave a comment  |  Email This Post
Tags: , , , , ,

What’s the Buzz?

BuzzofBIOLogo

Meet Deuteria Pharmaceuticals, winner of the 2012 Buzz of BIO competition. What is Buzz of BIO? Companies from around the world enter for the chance to win free registration and a company presentation in the BIO Business Forum. Who won? Deuteria Pharmaceuticals, Inc., a company that is pioneering ‘Deuterium-Enabled Chiral Switching’ (DECS) to improve the profile of drugs that interconvert between enantiomers both in vitro and in vivo. Stabilizing the preferred isomer improves the product Read More >

Business and Investments  |  Leave a comment  |  Email This Post
Tags: , , ,

We Are BIO

Jim Greenwood

Here’s what the Biotechnology Industry Organization is doing for you. This year, we challenged you to answer the question – What’s Your BIO? On behalf of the Biotechnology Industry Organization (BIO), I’d like to answer that question to illustrate how we advocate for federal, state and global policies to foster continued biotech breakthroughs, innovation and ingenuity. In addition to producing the BIO International Convention, we educate and engage public policy leaders in Washington, in state Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , , , , , , , , , , ,